495 related articles for article (PubMed ID: 15661380)
1. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
[TBL] [Abstract][Full Text] [Related]
2. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
3. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis.
Elias D; Akuffo H; Britton S
Trans R Soc Trop Med Hyg; 2005 May; 99(5):363-8. PubMed ID: 15780343
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
5. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
6. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
[TBL] [Abstract][Full Text] [Related]
7. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
8. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
[TBL] [Abstract][Full Text] [Related]
9. Patterns of cytokine production and proliferation by T lymphocytes differ in mice vaccinated or infected with Schistosoma mansoni.
Pemberton RM; Smythies LE; Mountford AP; Wilson RA
Immunology; 1991 Jul; 73(3):327-33. PubMed ID: 1908821
[TBL] [Abstract][Full Text] [Related]
10. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
[TBL] [Abstract][Full Text] [Related]
11. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
12. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
Fan X; Gao Q; Fu R
Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet radiation reduces resistance to Mycobacterium tuberculosis infection in BCG-vaccinated guinea pigs.
Jeevan A; Sharma AK; McMurray DN
Tuberculosis (Edinb); 2009 Nov; 89(6):431-8. PubMed ID: 19850524
[TBL] [Abstract][Full Text] [Related]
16. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.
Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A
J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641
[TBL] [Abstract][Full Text] [Related]
17. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
18. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.
Elias D; Britton S; Aseffa A; Engers H; Akuffo H
Vaccine; 2008 Jul; 26(31):3897-902. PubMed ID: 18554755
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
20. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H
Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
